NRx Pharmaceuticals, Inc. (NRXPW) NASDAQ

0.06

+0.0017(+2.89%)

Updated at January 13 03:45PM

Currency In USD

Valuation

Market Cap23.14M
Enterprise Value28.27M
P/E Ratio-1.24
PEG Ratio0.24
Price/Sales Ratio149.67
Price/Book Ratio-1.84
Enterprise/Revenue121.88
Enterprise/EBITDA-0.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-154.72
Operating Margin-57.04

Management Effectiveness

Return On Assets-2.54
Return On Equity1.39

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit-5,000
EBITDA-24.04M
Net Income-25.13M
Diluted EPS-2.39

Balance Sheet

Total Cash7.18M
Total Cash/Share0.32
Total Debt347,000
Total Debt/Equity-0.01
Current Ratio0.29
Book Value Per Share-1.16

Price History

52-Week Change-75.76
52-Week High0.16
52-Week Low0.06
Moving Average 50 Days0.08
Moving Average 200 Days0.09

Statistics

Average Volume13,613.61
Shares Outstanding28.06M
% Held by Institutions17.08

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A